HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...
GAITHERSBURG, Md. - GeneDx (NASDAQ:WGS), a genomic insights company with a market capitalization of $1.95 billion, announced the introduction of its ultraRapid Whole Genome Sequencing service, which ...
Though some outcomes were also poorer with an interval less than a year, these were less clinically significant, experts say.
Arkstone, the leader in laboratory infectious disease guidance and antimicrobial stewardship, proudly introduces NeoSuretm, a significant expansion of its OneChoice platform. Building upon OneChoice's ...
Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a new collaboration with the Institute for Follicular Lymphoma ...
Indoor lambing has benefits, but infections are a major risk. Learn how to reduce neonatal losses, improve hygiene, and protect your flock.
A new rat study explores lung function and placental changes in the presence of infection and inflammation. The study ...
Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome ...
Compared with non-Hispanic White (NHW) children, non-Hispanic Black (NHB) and Hispanic/Latino (HL) children with a headache diagnosis in the emergency department have lower rates of migraine diagnosis ...
From diagnosis to treatment, a speaker at the Masters of Pediatric Dermatology conference discussed updates for treating vascular birth marks in infants.In an interview with Healio, Mercedes E.